Skip to main content
Premium Trial:

Request an Annual Quote

US Senate Committee OKs Genetic Anti-Discrimination Bill

NEW YORK, May 22 - A US Senate committee yesterday approved legislation that would prohibit insurance companies and employers from discriminating against people based on their genetic information, according to a news report.
The bill, which has bipartisan support, may encourage more people to undergo genetic and molecular-diagnostic testing.


At its heart, the legislation would prohibit insurers and employers from asking for genetic information or require people to undergo genetic testing, the Associated Press said. Consequently, it would also bar health insurers from using genetic information to deny coverage or to set premiums, and deny employers the opportunity to base hiring and firing decision on the basis of genetic data.
"Today, public policy catches up with science to ensure that all Americans can realize the promise of advances made in the field of genetic science," the AP quoted Sen. Judd Gregg (R-NH), the chairman of the Senate Health, Education, Labor and Pensions Committee, as saying.

Health insurers and business groups claim "there is no evidence of abuse and the legislation is not needed," the AP said. "Federal nondiscrimination legislation has never been based on potential or theoretical discrimination, but, rather, on some appreciable history of actual discrimination," R. Bruce Josten of the US Chamber of Commerce said in a letter to Gregg, the AP reported.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.